This report provides a comprehensive strategic analysis of AstraZeneca, a multinational pharmaceutical company. It begins with an overview of the company, followed by stakeholder mapping and a detailed PESTLE analysis, examining political, economic, social, technological, legal, and environmental factors. The report then applies Porter's Five Forces to assess the competitive landscape and conducts a SWOT analysis to evaluate AstraZeneca's internal strengths, weaknesses, opportunities, and threats. Furthermore, it includes a strategic group analysis and discusses the industry life cycle of the pharmaceutical sector. The analysis highlights key findings and concludes with recommendations, offering a thorough understanding of AstraZeneca's strategic position and its approach to sustainable management within the dynamic pharmaceutical industry. The report emphasizes AstraZeneca's role in developing the COVID-19 vaccine and its impact on the company's performance.